HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING MEDICAID ACCESS TO RARE DISEASE THERAPIES AND ACCESS TO OUT OF STATE PROVIDERS HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); PROVISIONS RELATED TO OUTCOME BASED ARRANGEMENTS (OBA) AND VALUE BASED ARRANGEMENTS (VBA) HR 5539: OPTIMIZING RESEARCH PROGRESS HOPE AND NEW CURES ACT (ORPHAN CURES ACT); ALL PROVISIONS OF THE BILL HR 7384: CREATING HOPE REAUTHORIZATION ACT OF 2024: ALL PROVISIONS OF THE BILL HR 7635: THE 340B PHARMACEUTICAL ACCESS TO INVEST IN ESSENTIAL, NEEDED TREATMENTS & SUPPORT ACT OF 2024 (PATIENTS ACT); ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING HEMOPHILIA GENE THERAPY
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOMARIN PHARMACEUTICAL INC.
770 Lindaro Street, San Rafael, CA, 94901, US
JOHN EDWARD GREISSING JOHN EDWARD GREISSING KATHRYN LOWELL